Suppression of tumorigenic and metastatic potentials of human melanoma cell lines by mutated (143 Val-Ala) p53.

por Rauth, S., Green, A., Kichina, J., Shilkaitis, A.
Publicado 1998

Development of a new metastatic human breast carcinoma xenograft line.

por Mehta, R. R., Graves, J. M., Shilkaitis, A., Das Gupta, T. K.
Publicado 1998

p28, A first in class peptide inhibitor of cop1 binding to p53

por Yamada, T, Christov, K, Shilkaitis, A, Bratescu, L, Green, A, Santini, S, Bizzarri, A R, Cannistraro, S, Gupta, T K D, Beattie, C W
Publicado 2013